WithdrawnEarly Phase 1NCT04569903

Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Yale University
Principal Investigator
Edward Miller, MD
Yale University
Intervention
Computer algorithm for ATTR(device)
Eligibility
18 years · All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

Alnylam Pharmaceuticals Inc

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04569903 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials